Fengsheng Chen
Impact in
- Geriatrics and Gerontology top 10%
- Sirtuins and Resveratrol in Medicine
-
- Cancer-related molecular mechanisms research
Papers in
-
- Mechanisms of cancer metastasis 4
- RNA modifications and cancer 3
- Fibroblast Growth Factor Research 3
-
- Ferroptosis and cancer prognosis 4
- Lung Cancer Treatments and Mutations 3
- Co-authors
- Rongcheng Luo (11 shared papers)Aimin Li (9 shared papers)Wan Zhang (2 shared papers)Qian Geng (2 shared papers)Shenglan Gao (4 shared papers)Junyi Zhang (2 shared papers)Hua Xiao (4 shared papers)Chengliang Zhang (3 shared papers)
- Journals
- Cancer Letters (2 papers)International Immunopharmacology (2 papers)Immunology (1 paper)Journal of Advanced Research (1 paper)Lasers in Medical Science (1 paper)
- Partner nations
- ChinaUnited StatesMacao
In The Last Decade
Fengsheng Chen
41 papers receiving 452 citations
Peers
Comparison fields: 5 of 71
- Geriatrics and Gerontology 34
- Cancer Research 89
- Oncology 104
- Hepatology 30
- Pharmacology 32
Countries citing papers authored by Fengsheng Chen
This map shows the geographic impact of Fengsheng Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengsheng Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengsheng Chen more than expected).
Fields of papers citing papers by Fengsheng Chen
This network shows the impact of papers produced by Fengsheng Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengsheng Chen. The network helps show where Fengsheng Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Fengsheng Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 51 | |
| 2 | High expression of Sirt7 served as a predictor of adverse outcome in breast cancer. | 2015 | 43 |
| 3 | 2017 | 42 | |
| 4 | 2010 | 33 | |
| 5 | 2012 | 29 | |
| 6 | [GC-MS analysis of essential oil from the leaves of Psidium guajava]. | 1999 | 25 |
| 7 | 2015 | 24 | |
| 8 | 2021 | 21 | |
| 9 | 2018 | 21 | |
| 10 | 2021 | 16 | |
| 11 | 2021 | 16 | |
| 12 | 2009 | 15 | |
| 13 | 2015 | 13 | |
| 14 | 2024 | 10 | |
| 15 | 2014 | 10 | |
| 16 | 2011 | 9 | |
| 17 | 2017 | 8 | |
| 18 | 2020 | 8 | |
| 19 | [Coadministration of sorafenib and cisplatin inhibits proliferation of hepatocellular carcinoma HepG2 cells in vitro]. | 2008 | 8 |
| 20 | 2024 | 7 |
About Fengsheng Chen
Fengsheng Chen is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Immunology and Cancer Research, having authored 44 papers that have together received 461 indexed citations. Recurring topics across this work include Cancer Mechanisms and Therapy (4 papers), Mechanisms of cancer metastasis (4 papers), Ferroptosis and cancer prognosis (4 papers), Cancer, Hypoxia, and Metabolism (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers), RNA modifications and cancer (3 papers), Lung Cancer Treatments and Mutations (3 papers) and Fibroblast Growth Factor Research (3 papers). The work is most often cited by research in Geriatrics and Gerontology (34 citations), Cancer Research (89 citations), Oncology (104 citations), Hepatology (30 citations) and Pharmacology (32 citations). Fengsheng Chen has collaborated with scholars based in China, United States and Macao. Frequent co-authors include Rongcheng Luo, Aimin Li, Wan Zhang, Qian Geng, Shenglan Gao, Junyi Zhang, Hua Xiao, Chengliang Zhang, Rong Li and Feiye Liu. Their work appears in journals such as Cancer Letters, International Immunopharmacology, Immunology, Journal of Advanced Research and Lasers in Medical Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.